Primary enuresis. Nonorganic enuresis
Conditions
Interventions
Intervention 1: Nasal spray of Vasopressin, 10-20 microgram every night for three to four months and gradual tapering within 6 months. Intervention 2: 5 weeks treatment by IFC, three sessions per week
Treatment - Drugs
Treatment - Other
Nasal spray of Vasopressin, 10-20 microgram every night for three to four months and gradual tapering within 6 months
5 weeks treatment by IFC, three sessions per week for 20 minutes
Sponsors
Research management affairs, Yasuj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 5-15 years, presence of primary nocturnal enuresis that at least had history of two times nocturnal bed wetting per week Exclusion criteria: Any history of urinary tract infections, diurnal enuresis, organic disease and abnormality of urinary systems, resistance to other treatments modalities
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete improvment of enuresis. Timepoint: first month every two week then monthy for 6 months. Method of measurement: observation by parents.;Partial improvment of enuresis. Timepoint: First month every two weeks and then monthly for 6 months. Method of measurement: At least 50% decrease in bed wetting observed by parents. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of enuresis. Timepoint: one month after discontiuation of intervention. Method of measurement: observation by parents.;Adverse effects. Timepoint: First month every two weeks and then monthly for six months. Method of measurement: Report by patients or parents or observer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSadrollah Mehrabi
Yasuj University of Medical Sciences, Yasuj, Iran
Outcome results
None listed